Piramal Enterprises Ltd.

PEL

Market Cap
₹18,581 Cr.
P/E
0.00

Piramal Enterprises Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

1 No Data

Insufficient data to analyse

ROE
Latest
32.1%
3yr Average
13.81%
5yr Average
9.38%
Net Profit Margin
Latest
111.58%
3yr Average
48.96%
5yr Average
31.88%
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Borrowings Break-Up

locked
Source
|
Latest
|
locked
Historic

Borrowing Break-Up - Investor Type

locked
Source
|
Latest
|
locked
Historic

AUM Break-Up - NBFC

locked
Source
|
Latest
|
locked
Historic

Verticals -Wholesale

locked
Source
|
Latest
|
locked
Historic

Verticals -Retail

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    Peer Comparison
    Brands
    Lacto Calamine
    Saridon
    i-pill
    Suppliers
    Customers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Piramal Enterprises Ltd.
    One Upcoming Special Situation Opportunity - SOIC
    View the discussion on ValuePickr
    Piramal Enterprises and upcoming special situation - The Average Trader
    Special Situation - Demerger Of Piraml Enterprise & Piramal Pharma - SOIC
    Transformation of Piramal group post 2018 NBFC crisis - Business Today
    NBFC
    Buy Now Pay Later - Capital Mind
    Deep Dive into NBFC Business - Omkara Capital
    Asset Liability Mismatch: Why do NBFCs & Banks knowingly create it? - Dr Vijay Malik
    NBFC & Banks| How to find Multibaggers in this sector! - SOIC
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline